Demant's Q1 results met with neutral response from analyst
Tuesday’s quarterly report from Demant contains both some good and some bad elements, leaving readers with an overall neutral impression, according to a senior analyst at Sydbank.
by marketwire, translated by daniel pedersen
Demant was off to a good start to the year regarding its main business, Hearing Healthcare, which focuses on wholesale and retail sales of hearing aids, as well as sales of diagnostic tools.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Bank says not to expect surprises in Demant's Q1 report
For subscribers
Demant to divest hearing implant division to Cochlear
For subscribers
.jpg&w=384&q=75)
